Table 2.

Pre and post pentavalent vaccination antibody titres against tetanus, diphtheria toxoid, Haemophilus influenza B and Bordetella pertussis.

Name of antibody	Baseline			Post pentavalent vaccination
	PT1 (n=33)	PT2 (n=80)	FT (n=80)	PT1 (n=24)	PT2 (n=55)	FT (n=54)
Anti-Tetanus- IgG
% Seroprotection and 95% CI (≥0.01 IU/ml)	100 (100–100)	100 (100–100)	100 (100–100)	100 (100–100)	100 (100–100)	100 (100–100)
% Seroprotection and 95% CI (≥0.1 IU/ml)	93.93 (89.91–100)	100 (100–100)	100 (100–100)	100 (100–100)	100 (100–100)	100 (100–100)
GMT	1.56	2.71	3.57	1.44	1.47	1.82
Anti-Diphtheria-IgG
% Seroprotection and 95% CI (≥0.01 IU/ml)	87.87 (76–99.75)	92.5 (86.23–98.76)	97.5 (94.07–100.92)	100 (100–100)	100 (100–100)	100 (100–100)
% Seroprotection and 95% CI (≥0.1 IU/ml)	0	18.75 (9.47–28.02)	25 (15.51–34.48)	91.66 (81.6–100)	98.18 (95–100)	98.14 (95.19–100)
GMT	0.02	0.04	0.05	0.53	0.65	0.70
Anti PRP-IgG
% Seroprotection and 95% CI (≥0.15 µg/ml)	81.81 (67.78–95.85)	70 (59.1–80.89)	72.5 (62.71–82.28)	95.83 (88.56–100)	100 (100–100)	98.14 (95.19–100)
% Seroprotection and 95% CI (≥1 µg/ml)	6.06 (0–14.74)	12.5 (4.63–20.36)	16.25 (8.16–24.33)	54.16 (36.03–72.3)	80 (70.49–89.5)	90.74 (84.38–97.09)
GMT	0.21	0.32	0.35	1.58	4.20	7.71
Anti-Pertussis-IgG
% Seroprotection and 95% CI (>20 U/ml)	0 (0–0)	6.25 (0.49–12)	5 (0.22–9.77)	75 (59.23–90.76)	72.72 (62.14–83.31)	74.07 (64.47–83.67)
GMT	0.050	0.67	0.16	29.23	25.64	30.28

GMT, geometric mean titer; 95% CI, 95% confidence interval.